Note added:
This seems to be one of the many hopeless (because clumsily designed) studies that will show that the effect of this potential vaccine avoider is not significant.
This was made possible thanks to financial contributions from, among others: AstraZeneca, Roche Molecular Diagnostics, Janssen Pharmaceuticals, Pfizer INC, Glaxo-SmithKline. (as neatly stated in the "Declaration of interests")
Disclaimer: this study has not yet been peer-reviewed and the design can be criticized if the sample is flawed. That data is not yet available.
After the Ivermectin story, this looks like a medicinal blog. That is not the intention; I would rather leave that to professionals, but I am afraid that we will hear little about it in the media. They mainly see medication as an obstacle to vaccination readiness.
A very short summary of the Oxford University study:
- Patients with chronic respiratory diseases were found to be significantly underrepresented in COVID-19 hospital admissions. This led to the hypothesis that respiratory drugs could also work with Covid.
- Further randomized study by NIHR Oxford Biomedical Research Centre (BRC) shows that the puff containing Budesonide, used against asthma, reduces Covid hospitalizations by 90%.
- LONG-COVID symptoms are also markedly reduced.
- Budesonide is one of the most widespread drugs, also readily available in less developed countries.
This drug can hopefully soon be on the pharmacy shelf alongside Ivermectin, Dexamethazone, HCQ/Zinc.
Or in a drawer, in a back room of the RIVM.
Jaap van Dissel will undoubtedly find that Budesonide is more effective if it is introduced through droplets, dirty hands and contaminated surfaces.
The Article from Oxford University: https://www.ox.ac.uk/news/2021-02-09-common-asthma-treatment-reduces-need-hospitalisation-covid-19-patients-study#
The full pre-print (not yet peer-reviewed) report: https://www.medrxiv.org/content/10.1101/2021.02.04.21251134v1.full-text
Nederlandstalig artikel op Zelfzorgcovid19.nl: https://zelfzorgcovid19.nl/oxford-onderzoek-90-minder-kans-op-ziekenhuisopname-door-budesonide/
